Related Experiment Video

Updated: Jul 4, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K

Infectious Pulmonary Diseases

Rachel Rafeq1, Lauren A Igneri2

  • 1Emergency Medicine, Department of Pharmacy, Cooper University Healthcare, 1 Cooper Plaza, Camden, NJ 08103, USA.

Infectious Disease Clinics of North America
|January 27, 2024
PubMed

Insights

Pneumonia, a deadly lower respiratory infection, occurs when pathogens accumulate in the lungs. Treatment varies by pneumonia type: community-acquired, hospital-acquired, or ventilator-associated.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Pneumonia is a severe lower respiratory tract infection.
  • It results from the inability to clear pathogens, leading to lung inflammation and fluid congestion.
  • Lower respiratory infections are the most common fatal communicable disease globally.

Purpose of the Study:

  • To define pneumonia and its clinical diagnostic criteria.
  • To categorize pneumonia into community-acquired, hospital-acquired, and ventilator-associated types.
  • To outline therapeutic considerations based on disease severity and specific pathogen risk factors.

Main Methods:

  • The study defines pneumonia based on the Infectious Diseases Society of America criteria.
  • It involves identifying new lung infiltrates alongside clinical signs of infection.
  • Classification into three main categories is based on the acquisition setting.

Main Results:

  • Pneumonia involves pathogen accumulation, inflammation, and fluid in lung parenchyma.
  • Diagnostic criteria include new lung infiltrate, fever, purulent sputum, leukocytosis, and decreased oxygenation.
  • Pneumonia is categorized into community-acquired, hospital-acquired, and ventilator-associated infections.

Conclusions:

  • Pneumonia necessitates prompt diagnosis and tailored treatment strategies.
  • Understanding the type of pneumonia and risk factors is crucial for effective therapy.
  • Effective management of pneumonia is vital due to its high mortality rate.
Keywords:
AllergiesAntimicrobial stewardshipCommunity-acquired pneumoniaCross-sensitivityHospital-acquired pneumoniaMRSA nasal screeningProcalcitoninVentilator-associated pneumonia

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.7K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

22.8K

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
840
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
239
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
239
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
274
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
332